PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis.
Maria PalmieriMargherita BaldassarriFrancesca FavaAlessandra FabbianiGiuseppe Maria CampennìMaria Antonietta MencarelliRossella TitaStefania MarsiliAlessandra RenieriElisa FrullantiPublished in: Cancer cell international (2019)
Thanks to liquid biopsy may be possible to introduce new experimental drugs in the correct therapeutic window which would lead in the near future to an effective treatment which otherwise remains challenging.